Jump to content

Search the Community

Showing results for tags 'COVID-19 vaccine'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type



Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Salutation


Country


Occupation


Organization


Website


I am joining because:

Found 4 results

  1. This playlist is part of a set of 52 COVID-19 FAQ explainer videos to answer the frequently asked questions about the types of vaccines including eligibility, safety, at-risk groups, rollout, intervals, common side effects, importance of two doses and who needs the vaccine and many more.
  2. In recognition of the critical importance of COVID-19 vaccines and the need to understand their safety, the CONSIDER (COvid-19 vacciNe Safety questIons anD hEalthcare pRoviders) working group (WG) was created in September 2020. The CONSIDER WG aims to provide clear, comprehensive answers to questions pertaining to COVID-19 vaccine safety prior to, and during the vaccines roll out to 1) facilitate scientific discussion between stakeholders, including front line health workers with potential vaccine recipients and 2) increase comprehension and transparency of information to facilitate accep
  3. In episode 4 of our COVID-19 Road to a vaccine series, we spoke with Professor Kanta Subbarao. Professor Subbarao has been the Director of the World Health Organisation Collaborating Centre for Reference and Research on Influenza since 2016, based at The Doherty Institute at the University of Melbourne, Australia. In episode 5 of our COVID-19 Road to a vaccine series, we spoke with Professor Terry Nolan, who is a Redmond Barry Distinguished Professor at the Doherty Institute for Infection and Immunity. He heads up VIRGO, the vaccine and immunisation research group, a collaboration betwee
  4. In Episode 2 of our podcast series 'COVID-19, Road to a Vaccine' we speak with Professor Kathryn Edwards from Vanderbilt University School of Medicine in Nashville, Tennessee, about the important topic of vaccine safety when developing a new vaccine, including some of the challenges faced in the COVID19 vaccine development pathway. In Episode 3, Associate Professor Nigel Crawford discusses the development of a COVID-19 vaccine with Professor Andrew Pollard, head of The Oxford Vaccine Group, who is co-leading The Oxford Vaccine Centre’s COVID-19 vaccine trial.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines